HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses.

Adult C-Reactive Protein / metabolism CD4 Lymphocyte Count CD8-Positive T-Lymphocytes / immunology Coinfection / blood Cytokines / blood Female GATA3 Transcription Factor / blood HIV Infections / immunology HIV-1 / immunology Humans Latent Tuberculosis / pathology Male Mycobacterium tuberculosis / immunology Programmed Cell Death 1 Receptor / blood Th2 Cells / immunology Tuberculosis, Pulmonary / immunology
CD4 T cells HIV Mycobacterium tuberculosis exhaustion

Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 03 10 2018
accepted: 28 11 2018
pubmed: 14 12 2018
medline: 21 11 2019
entrez: 14 12 2018
Statut: epublish

Résumé

Human immunodeficiency virus (HIV) infection is the major risk factor predisposing for

Identifiants

DOI: 10.1128/JVI.01728-18 PMID: 30541853 PMC: PMC6384080
pubmed: 30541853
pii: JVI.01728-18
doi: 10.1128/JVI.01728-18
pmc: PMC6384080
pii:
doi:

Substances chimiques

Cytokines 0
GATA3 Transcription Factor 0
PDCD1 protein, human 0
Programmed Cell Death 1 Receptor 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 Amelio et al.

Références

Science. 2001 Jun 8;292(5523):1907-10
pubmed: 11397944
Clin Infect Dis. 2011 May;52 Suppl 4:S284-9
pubmed: 21460286
Eur J Immunol. 2013 Jun;43(6):1568-77
pubmed: 23456989
J Infect. 2014 Dec;69(6):533-45
pubmed: 24975174
J Immunol. 2005 Oct 15;175(8):5333-40
pubmed: 16210639
J Virol. 2015 Dec 09;90(4):1858-71
pubmed: 26656693
Cell. 2006 Sep 22;126(6):1121-33
pubmed: 16990136
AIDS. 1990 Oct;4(10):981-5
pubmed: 2261127
N Engl J Med. 1996 Dec 26;335(26):1956-61
pubmed: 8960475
J Infect Dis. 2005 Jan 15;191(2):150-8
pubmed: 15609223
N Engl J Med. 1989 Mar 2;320(9):545-50
pubmed: 2915665
Clin Infect Dis. 2010 May 15;50 Suppl 3:S215-22
pubmed: 20397951
Curr HIV/AIDS Rep. 2011 Mar;8(1):4-11
pubmed: 21188556
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
Nat Rev Microbiol. 2014 Apr;12(4):289-99
pubmed: 24590243
Cytometry A. 2011 Feb;79(2):167-74
pubmed: 21265010
EBioMedicine. 2015 Apr 1;2(4):334-340
pubmed: 26114158
J Clin Invest. 2011 May;121(5):1827-33
pubmed: 21519144
Nature. 2001 Mar 1;410(6824):106-11
pubmed: 11242051
Trends Microbiol. 2016 May;24(5):323-324
pubmed: 26916790
J Infect Dis. 2008 Dec 1;198(11):1590-8
pubmed: 19000013
Nature. 1996 Dec 5;384(6608):474-8
pubmed: 8945476
Eur J Immunol. 2013 Apr;43(4):939-48
pubmed: 23436562
J Exp Med. 2008 Nov 24;205(12):2717-25
pubmed: 18981239
J Immunol. 2017 Sep 15;199(6):2069-2080
pubmed: 28760884
J Exp Med. 2006 Oct 2;203(10):2281-92
pubmed: 16954372
Blood. 2004 Oct 15;104(8):2432-40
pubmed: 15265797
Nat Genet. 1999 Apr;21(4):370-8
pubmed: 10192386
Clin Microbiol Rev. 2014 Jul;27(3):441-62
pubmed: 24982316
Nature. 2005 Apr 28;434(7037):1093-7
pubmed: 15793563
PLoS Negl Trop Dis. 2017 Jul 31;11(7):e0005817
pubmed: 28759590
J Infect Dis. 2008 Apr 1;197(7):990-9
pubmed: 18419535
Nature. 2006 Sep 21;443(7109):350-4
pubmed: 16921384
Infect Immun. 2011 Apr;79(4):1407-17
pubmed: 21245275
J Immunol. 2017 Aug 9;:
pubmed: 28794233
J Infect Dis. 2018 May 5;217(11):1782-1792
pubmed: 29546381
Nat Med. 2006 Oct;12(10):1198-202
pubmed: 16917489
PLoS One. 2016 Jul 19;11(7):e0159132
pubmed: 27434276
N Engl J Med. 2001 Oct 11;345(15):1098-104
pubmed: 11596589
Clin Infect Dis. 2010 May 15;50 Suppl 3:S201-7
pubmed: 20397949
Clin Infect Dis. 2015 Feb 1;60(3):432-7
pubmed: 25362202
J Virol. 2005 Dec;79(23):14595-605
pubmed: 16282459
Lancet Infect Dis. 2017 Dec;17(12):1285-1292
pubmed: 28847636
Eur J Immunol. 2008 May;38(5):1321-30
pubmed: 18398932
J Immunol. 2010 Jun 1;184(11):6537-44
pubmed: 20435929
Arch Intern Med. 2003 May 12;163(9):1009-21
pubmed: 12742798
PLoS Pathog. 2014 Sep 25;10(9):e1004380
pubmed: 25255144
Clin Infect Dis. 2005 Dec 15;41(12):1772-82
pubmed: 16288403
J Exp Med. 2010 Sep 27;207(10):2187-94
pubmed: 20819927
Nat Rev Microbiol. 2018 Feb;16(2):80-90
pubmed: 29109555
Am J Respir Cell Mol Biol. 1998 Sep;19(3):513-21
pubmed: 9730880
J Exp Med. 2014 Sep 22;211(10):2033-45
pubmed: 25225461
Sci Rep. 2017 Dec 19;7(1):17854
pubmed: 29259310
Immunol Lett. 2018 Jun;198:33-43
pubmed: 29635002

Auteurs

Patrizia Amelio (P)

Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Damien Portevin (D)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Jerry Hella (J)

Ifakara Health Institute, Bagamoyo, Tanzania.

Klaus Reither (K)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Lujeko Kamwela (L)

Ifakara Health Institute, Bagamoyo, Tanzania.

Omar Lweno (O)

Ifakara Health Institute, Bagamoyo, Tanzania.

Anneth Tumbo (A)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
Ifakara Health Institute, Bagamoyo, Tanzania.

Linda Geoffrey (L)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
Ifakara Health Institute, Bagamoyo, Tanzania.

Khalid Ohmiti (K)

Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Song Ding (S)

EuroVacc Foundation, Lausanne, Switzerland.

Giuseppe Pantaleo (G)

Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Claudia Daubenberger (C)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Matthieu Perreau (M)

Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland Matthieu.Perreau@chuv.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › HIV Infection Functionally Impairs...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines du sang › Immunoprotéines › Protéine C-réactive › HIV Infection Functionally Impairs...
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiogiques du sang › Hémogramme › Numération des leucocytes › Numération des lymphocytes › Numération des lymphocytes CD4 › HIV Infection Functionally Impairs...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD8+ › HIV Infection Functionally Impairs...
questionsmedicales.fr › Infection › Co-infection › HIV Infection Functionally Impairs...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › HIV Infection Functionally Impairs...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Facteurs de transcription › Facteurs de transcription GATA › Facteur de transcription GATA-3 › HIV Infection Functionally Impairs...
questionsmedicales.fr › Maladies du système immunitaire › Déficits immunitaires › Infections à VIH › HIV Infection Functionally Impairs...
questionsmedicales.fr › Virus › Virus à ARN › Retroviridae › Lentivirus › Lentivirus des primates › VIH (Virus de l'Immunodéficience Humaine) › VIH-1 (Virus de l'Immunodéficience Humaine de type 1) › HIV Infection Functionally Impairs...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › HIV Infection Functionally Impairs...
questionsmedicales.fr › Infection › Infection latente › Tuberculose latente › HIV Infection Functionally Impairs...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Bâtonnets à Gram positif › Bâtonnets asporogènes à Gram positif › Bâtonnets asporogènes réguliers à Gram positif › Mycobacteriaceae › Mycobacterium › Mycobacterium tuberculosis › HIV Infection Functionally Impairs...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Antigènes de différenciation › Antigènes de différenciation des lymphocytes T › Récepteur-1 de mort cellulaire programmée › HIV Infection Functionally Impairs...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Lymphocytes T auxiliaires › Lymphocytes auxiliaires Th2 › HIV Infection Functionally Impairs...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Tuberculose pulmonaire › HIV Infection Functionally Impairs...